scorecardresearch
Thursday, April 25, 2024
Support Our Journalism
HomeWorldHCQ has ‘tremendous, rave reviews’, Trump says after finishing a course of...

HCQ has ‘tremendous, rave reviews’, Trump says after finishing a course of treatment

Trump, who at 73 is in an age group at which contracting Covid-19 can be especially dangerous, began HCQ treatments in consultation with White House physicians.

Follow Us :
Text Size:

Washington: President Donald Trump said he completed his course of treatment with hydroxychloroquine, the anti-malaria drug he’s promoted as a therapy for coronavirus despite an outcry from medical professionals about its unproven efficacy and potential side effects.

“Finished, just finished,” Trump said in an interview on Sinclair Broadcast Group program “Full Measure with Sharyl Attkisson” that was taped Friday and aired Sunday. “By the way, I’m still here to the best of my knowledge. Here I am.”

There’s scant evidence that hydroxychloroquine is effective against the coronavirus. The Food and Drug Administration on April 24 cautioned against its use for Covid-19, the illness caused by the coronavirus, outside of a hospital setting or clinical trial, citing a risk of heart rhythm problems.

Trump, who at 73 is in an age group at which contracting Covid-19 can be especially dangerous, began the treatments in consultation with White House physicians after Vice President Mike Pence’s press secretary, Katie Miller, tested positive for coronavirus on May 8. A White House valet also contracted the virus around the same time.

“I believe in it enough that I took a program, because I had two people in the White House that tested positive, I figured maybe it’s a good thing to take a program,” Trump said.

“You know we take a little bit of a period of time, I think it was two weeks, but hydroxy has had tremendous, if you look at it, tremendous, rave reviews.” –Bloomberg


Also read: HCQ breakthrough: ICMR finds it’s effective in preventing coronavirus, expands its use


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular